Traders are so tuned into the word miss that they often MISS something EXTREMELY IMPORTANT. I think that is what happened here.
Man Davies
Posts (4982)
HERE IS WHAT YOU MISSED:
*
A secondary endpoint of CSF levels of IL1-beta, a core biomarker of neuroinflammation from baseline to day 28, was met, Cassava said. The drug was also found to be safe and well-tolerated.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214864/
Systematic review: Inflammation in Alzheimer's disease (AD) has emerged as a central pathology that likely plays a role in onset and progression of the disease.
*
Per the company,
CSF levels of IL1-beta, a core biomarker of neuroinflammation ... was met
So, BEFORE you DUMP, you may want to RECONSIDER. Neuro Inflammation is core to the onset and progression of Alzheimers. THAT aspect of the PTI-125s efficacy ALONE, makes it A BLOCKBUSTER DRUG! ;)
ADDED TON OF SHARES
ADDED BIG POSITION HERE
F $SBUX TOO
I FULLY INTEND TO SHORT THAT SHIT INTO THE GROUND
L<- DAMN THAT IS QUEER
When will this china stock be delisted?
Personally plan to short this shit into OBLIVION
If you ever hear me BITCH on a board, it is about my OWN position in that stock.
